UBS AM’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

UBS AM’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$464K	Sell	2,933 -13	-0.4%	-$1.76K	﹤0.01%	2566
2026 Q1	$376K	Buy	2,946 +2,728	+1,251%	+$341K	﹤0.01%	2615
2025 Q4	$26.6K	Buy	+218	New	+$25K	﹤0.01%	2700
2019 Q4	–	Sell	-215	Closed	-$16.4K	–	2876
2019 Q3	$16.4K	Hold	215	–	–	﹤0.01%	2786
2019 Q2	$18.9K	Sell	215 -106	-33%	-$9.04K	﹤0.01%	2751
2019 Q1	$29.1K	Buy	321 +292	+1,007%	+$24.8K	﹤0.01%	2658
2018 Q4	$2.08K	Sell	29 -36	-55%	-$2.9K	﹤0.01%	2725
2018 Q3	$6.23K	Sell	65 -18	-22%	-$1.75K	﹤0.01%	2680
2018 Q2	$7.9K	Sell	83 -6	-7%	-$551	﹤0.01%	2692
2018 Q1	$7.81K	Buy	89 +53	+147%	+$4.84K	﹤0.01%	2586
2017 Q4	$3.06K	Hold	36	–	–	﹤0.01%	2543
2017 Q3	$3.12K	Hold	36	–	–	﹤0.01%	2493
2017 Q2	$2.78K	Hold	36	–	–	﹤0.01%	2481
2017 Q1	$2.5K	Hold	36	–	–	﹤0.01%	2432
2016 Q4	$2K	Buy	+36	New	+$2.22K	﹤0.01%	2452

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

UBS AM's XBI Position: Q2 2026 in Review

UBS AM reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 0.44% in Q2 2026, selling an estimated $1.76K and leaving 2,933 shares worth $464K. The position accounts for ﹤0.01% of the portfolio, ranked #2566.

UBS AM first reported a position in XBI in Q4 2016 and has held it in 15 quarters since. 932 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

UBS AM held 2,933 shares of State Street SPDR S&P Biotech ETF worth $464K as of Q2 2026.
UBS AM sold 13 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $1.76K.
State Street SPDR S&P Biotech ETF made up ﹤0.01% of UBS AM's portfolio in Q2 2026, its #2566 holding.
UBS AM first reported a position in State Street SPDR S&P Biotech ETF in Q4 2016 and has held it in 15 quarters since.
932 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.